Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.292
-0.005 (-1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 16 | 40 | 577 | 651 | 754 | 752 | |
Market Cap Growth | -90.77% | -92.99% | -11.37% | -13.64% | 0.26% | 46.64% | |
Enterprise Value | 7 | -35 | 400 | 462 | 626 | 507 | |
Last Close Price | 0.29 | 0.74 | 10.74 | 12.18 | 15.13 | 16.11 | |
PE Ratio | - | -0.34 | -6.74 | -6.98 | 85.30 | -6.46 | |
PS Ratio | 1.45 | 1.93 | 13.78 | 28.28 | 5.58 | 37.82 | |
PB Ratio | 1.38 | 0.71 | 3.63 | 2.86 | 3.03 | 4.03 | |
P/FCF Ratio | -0.17 | -0.43 | -7.33 | -10.83 | -129.19 | -6.88 | |
P/OCF Ratio | -0.18 | -0.44 | -7.33 | -10.84 | -137.41 | -6.88 | |
EV/Sales Ratio | 0.60 | -1.69 | 9.55 | 20.05 | 4.64 | 25.52 | |
EV/EBITDA Ratio | 0.10 | 0.29 | -4.58 | -5.20 | 111.96 | -4.55 | |
EV/EBIT Ratio | 0.10 | 0.29 | -4.57 | -5.18 | 116.31 | -4.54 | |
EV/FCF Ratio | 0.12 | 0.38 | -5.08 | -7.68 | -107.32 | -4.65 | |
Debt / Equity Ratio | 4.07 | 0.76 | 0.01 | 0.02 | 0.02 | 0.02 | |
Debt / EBITDA Ratio | - | - | - | - | 0.79 | - | |
Debt / FCF Ratio | -0.57 | -0.46 | -0.02 | -0.06 | -0.90 | -0.04 | |
Asset Turnover | 0.11 | 0.14 | 0.20 | 0.09 | 0.54 | 0.09 | |
Inventory Turnover | 35.09 | 43.64 | 39.46 | - | - | - | |
Quick Ratio | 4.20 | 4.09 | 6.39 | 9.55 | 9.90 | 3.66 | |
Current Ratio | 4.59 | 4.54 | 7.20 | 9.84 | 10.55 | 3.86 | |
Return on Equity (ROE) | -184.32% | -109.80% | -44.25% | -37.12% | 3.86% | -66.41% | |
Return on Assets (ROA) | -63.43% | -49.30% | -25.49% | -21.49% | 1.34% | -32.94% | |
Return on Capital (ROIC) | -77.80% | -58.20% | -27.92% | -22.94% | 1.51% | -43.00% | |
Earnings Yield | -694.07% | -292.78% | -14.81% | -13.58% | 1.12% | -14.15% | |
FCF Yield | -520.65% | -233.34% | -13.65% | -9.23% | -0.77% | -14.53% | |
Buyback Yield / Dilution | -1.24% | -0.92% | -5.79% | -5.85% | -12.29% | -18.88% | |
Total Shareholder Return | -1.24% | -0.92% | -5.79% | -5.85% | -12.29% | -18.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.